Target intelligence / Profile preview

Mycobacterium tuberculosis 50S ribosomal subunit peptidyl-tRNA site (Mtb 50S P-site)

Target
Mtb 50S P-site
Molecular classification
Ribonucleoprotein complex, Bacterial ribosome subunit, Ribosomal RNA-protein complex
01

Overview

The Mycobacterium tuberculosis 50S ribosomal subunit P-site (peptidyl-tRNA site) is a fundamental component of the bacterial translation machinery, responsible for holding the tRNA molecule linked to the growing polypeptide chain (Belousoff et al., 2017). Located within the peptidyl transferase center (PTC) of the 50S subunit, this site is primarily composed of highly conserved segments of the 23S ribosomal RNA. It serves as a critical target for the oxazolidinone class of antibiotics, including linezolid and tedizolid, which are essential for the treatment of multidrug-resistant tuberculosis (MDR-TB) (Wilson, 2014). These drugs bind to the P-site and the adjacent A-site, sterically hindering the formation of the 70S initiation complex and the subsequent elongation steps of protein synthesis (Richter et al., 2007). While the target is specific to bacteria, structural similarities between the bacterial P-site and human mitochondrial ribosomes can lead to clinical toxicities such as myelosuppression and neuropathy during prolonged therapy (StatPearls, 2023). Resistance to drugs targeting this site typically arises through point mutations in the 23S rRNA or associated ribosomal proteins like L3, which alter the binding pocket and reduce drug affinity (PubMed, 2021).

Other names
M. tuberculosis 50S P-sitePeptidyl-tRNA binding site50S ribosomal P-siteMycobacterium tuberculosis 50S peptidyl siteMtb 50S PTC P-site
02

Mechanism of action

Inhibition of protein synthesis by binding to the 23S rRNA of the 50S subunit, which prevents the proper positioning of aminoacyl-tRNA and inhibits the formation of the 70S initiation complex or the translocation of peptidyl-tRNA (Wilson, 2014; Belousoff et al., 2017).

03

Biological functions

Protein synthesisTranslation elongationPeptidyl transferInitiation complex formation
04

Disease associations

TuberculosisInfectionMycobacterial infection
05

Safety considerations

Myelosuppression (thrombocytopenia, anemia, leukopenia)Peripheral neuropathyOptic neuropathyLactic acidosisSerotonin syndrome due to MAO inhibition
06

Interacting drugs

Linezolid

4 more in the full profile.

07

Biomarkers

23S rRNA (rrl) gene mutations (e.g., G2576T)Ribosomal protein L3 (rplC) mutationsSputum culture conversionTime to positivity (TTP) in liquid culture

Beyond the preview

Go deeper on Mycobacterium tuberculosis 50S ribosomal subunit peptidyl-tRNA site (Mtb 50S P-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis 50S ribosomal subunit peptidyl-tRNA site (Mtb 50S P-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call